Genetic polymorphism of CYP2D6*2 C→T 2850, GSTM1, NQO1 genes and their correlation with biomarkers in manganese miners of Central India

Chemosphere

Volumn 81, Issue 10, 2010, Pages 1286-1291

  Vinayagamoorthy, Nadimuthu ^a   Krishnamurthi, Kannan ^a   Devi, Sivanesan Saravana ^a   Naoghare, Pravin K ^a   Biswas, Raka ^a   Biswas, Arup R ^a   Pramanik, Sreemanta ^a   Shende, Ashok R ^a   Chakrabarti, Tapan ^a  

^a NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUTE   (India)

Author keywords

CYP2D6*2; GSTM1; Manganese miners; NQO1; Polymorphism; Prolactin

Indexed keywords

BLOOD; CERAMIC PLANTS; GENES; MINERS; POLYMERASE CHAIN REACTION; POLYMORPHISM; QUINONE;

CERAMIC INDUSTRIES; GENE-GENE INTERACTION; GENETIC POLYMORPHISMS; GLUTATHIONE S-TRANSFERASES; GSTM1; NQO1; PROLACTIN; RESTRICTION FRAGMENT LENGTH POLYMORPHISMS;

MANGANESE MINES;

BIOLOGICAL MARKER; CYTOCHROME P450 2D6; GLUTATHIONE TRANSFERASE M1; MANGANESE; PROLACTIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

BIOMARKER; BLOOD; CORRELATION; CYTOCHROME; ENZYME ACTIVITY; GENOTYPE; MANGANESE; METABOLISM; POLYMERASE CHAIN REACTION; POLYMORPHISM;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; INDIA; MALE; MINER; PROLACTIN BLOOD LEVEL; TRACE METAL BLOOD LEVEL;

EID: 78149281696     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2010.08.047     Document Type: Article

References (34)

1. Brosen K., Gram L.F. Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur. J. Clin. Pharmacol. 1989, 36:537-547.
2. Dahl M.L., Bertilsson L. Genetically variable metabolism of antidepressants and neuroleptic drugs in man. Pharmacogenetics 1993, 3:61-70.
3. Devi S.S., Vinayagamoorthy N., Agrawal M., Biswas A., Biswas R., Naoghare P., Kumbhakar S., Krishnamurthi K., Hengstler J.G., Hermes M., et al. Distribution of detoxifying genes polymorphism in Maharastrian population of central India. Chemosphere 2008, 70(10):1835-1839.
4. Donaldson J. The pathophysiology of trace metal: neurotransmitter interaction in the CNS. Trends Pharmacol. Sci. 1981, 75-77.
5. Ellingsen D.G., Haug E., Gaarder P.I., Bast-Pettersen R., Thomassen Y. Endocrine and immunologic markers in manganese alloy production workers. Scand. J. Work Environ. Health 2003, 29(3):230-238.
6. Erikson K.M., Aschner M. Manganese neurotoxicity and glutamate-GABA interaction. Neurochem. Int. 2003, 4:475-480.
7. Ferraz H.B., Bertolucci P.H., Pereira J.S., Lima J.G., Andrade L.A. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988, 38(4):550-553.
8. Graham D.G. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 1984, 5:83-95.
9. Heim M., Meyer U.A. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet 1990, 336:529-532.
10. Ikeda S., Yamaguchi Y., Sera Y., Ohshiro H., Uchino S., Yamashita Y., et al. Manganese deposition in the globus pallidus in patients with biliary atresia. Transplantation 2000, 69:2339-2343.
11. Kawai S., Nishio K., Nakamura S., Sekido Y., Niwa T., Hamajima N. Multiplex PCR with confronting two-pair primers for CYP1A1 Ile462Val, GSTM1, GSTT1, and NQO1 C609T. Asian Pac. J. Cancer Prev. 2005, 6:346-352.
12. Kim E.A., Cheong H.K., Joo K.D., Shin J.H., Lee J.S., Choi S.B., Kim M.O., Lee I.J., Kang D.M. Effect of manganese exposure on the neuroendocrine system in welders. Neurotoxicology 2007, 28:263-269.
13. Kuehl B.L., Paterson J.W., Peacock J.W., Paterson M.C., Rauth A.M. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br. J. Cancer 1995, 72:555-561.
14. Larson R.A., Wang Y., Banerjee M., Wirmels J., Hartford C., Lebeau M.M., Smith M.T. Prevalence of the inactivating 609C-T polymorphism in the NAD(P)H quinone oxidoreductase (NQQ1) genes in patients with primary and therapy-related myeloid leukemia. Blood 1999, 94:803-807.
15. Lee Y.L., Lin Y.C., Lee Y.C., Wang J.Y., Hsiue T.R., Guo Y.L. Glutathione S-transferase P1 gene polymorphism and air pollution as interactive risk factors for childhood asthma. Clin. Exp. Allergy 2004, 34:1707-1713.
16. Li C.C. First Course in Population Genetics 1976, Boxwood press, Pacific Grove, CA, USA. first ed.
17. Meco G., Bonifati V., Vanacore N., Fabrizio E. Parkinsonism after chronic exposure to the fungicide maneb. Scand. J. Work Environ. Health 1994, 20:301-305.
18. Mirowitz S.A., Westrich T.J., Hirsch J.D. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 1991, 181:117-120.
19. Myers J.E., Thompson M.L., Naik I., Theodorou P., Esswein E., Tassell H., et al. The utility of biological monitoring for manganese in ferroalloy smelter workers in South Africa. Neurotoxicology 2003, 24(6):875-883.
20. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J. Neurol. Sci. 1999, 162:102-105.
21. Niu Q., He S., Chen Y., Dai F. Effect on manganese exposure on blood prolactin and plasma renin activity. Wei Sheng Yan Jiu 2001, 30(2):91-92.
22. Pal P.K., Samii A., Calne D.B. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 1999, 20:227-238.
23. Roels H.A., Ghyselen P., Buchet J.P., Ceulemans E., Lauwerys R.R. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br. J. Ind. Med. 1992, 49(1):25-34.
24. Shinji O., Iwao H., Saeko T., Ayako F., Kaoru N., Shosuke H. Mechanism for manganese enhancement of dopamine-induced oxidative DNA damage and neuronal cell death. Free Radic. Biol. Med. 2006, 41:748-756.
25. Smargiassi A., Mutti A. Peripheral biomarkers and exposure to manganese. Neurotoxicology 1999, 20:401-406.
26. Stohs S.J., Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 1995, 18:321-336.
27. Tasker L., Mergler D., de Grosbois S., Smargiassi A., Lafond J. Blood manganese content at birth and cord serum prolactin levels. Neurotoxicol. Teratol. 2004, 26:811-815.
28. Wang L.D., Zheng S., Liu B., Zhou J.X., Li Y.J., Li J.X. CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high incidence area in north China. World J. Gastroenterol. 2003, 9:1394-1397.
29. Wasserman G.A., Liu X., Parvez F., Ahsan H., Levy D., Factor-Litvak P. Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health. Perspect. 2006, 114:124-129.
30. Winski S.L., Koutalos Y., Bentley D.L., Ross D. Subcellular localization of NAD(P)H: quinone oxidoreductase I in human cancer cells. Cancer Res. 2002, 62:1420-1424.
31. Xu Q.S., Hong Y.C., Lee K.H. Genetic polymorphisms of the CYP450 1A1, CYP450 2E1, GSTM1, GSTT1, and GSTP1. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005, 22:347-349. (in Chinese).
32. You W.C., Hong J.Y., Zhang L., Pan K.F., Pee D., Li J.Y. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol. Biomarkers Prev. 2005, 14:451-458.
33. Zhang J.H., Li Y., Wang R., Geddert H., Guo W., Wen D.G., Chen Z.F., Wei L.Z., Kuang G., He M., et al. NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J. Gastroenterol. 2003, 9:1390-1393.
34. Zheng Y.X., Chan P., Pan Z.F., Shi N.N., Wang Z.X., Pan J., Liang H.M., Niu Y., Zhou X.R., He F.S. Polymorphism of metabolic genes and susceptibility to occupational chronic manganism. Biomarkers 2002, 7:337-346.